TM4SF1 Protein-VLP, Human (HEK293)

TM4SF1 Protein-VLP, Human (HEK293) is recommended for animal immunization, ELISA, PK assay. If VLP control is required, it is recommended HY-P702775. May have binding signals with Anti-His antibodies.

The TM4SF1 Protein-VLP, identified in tumor cells, is notably present in high molecular weight complexes, indicating its involvement in intricate cellular processes within these malignancies. Furthermore, the protein interacts with SDCBP2, emphasizing its association with specific molecular pathways and potential roles in cellular signaling or regulatory mechanisms. This insight into TM4SF1 Protein-VLP's molecular interactions and its presence in tumor cell complexes contributes to the understanding of its functional significance within the context of tumorigenesis.

Immobilized Human TM4SF1 VLP at 5μg/ml (100μl/Well) on the plate. Dose response curve for Anti-TM4SF1 Antibody, hFc Tag with the EC₅₀ of 6.3ng/ml determined by ELISA.

Human

HEK293

Tag Free

P30408 (M1-C202)

4071  [NCBI]

Full Length

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized powder.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Normally 8% trehalose is added as protectant before lyophilization.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O.

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.